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_____________________________________________________________________________________ 
 
RNA triphosphatase catalyzes the first step in 
mRNA cap formation, hydrolysis of the terminal 
phosphate from the nascent mRNA transcript. 
The RNA triphosphatase from the protozoan 
parasite Trypanosoma cruzi, TcCet1, belongs to 
the family of triphosphate tunnel 
metalloenzymes (TTMs). TcCet1 is a promising 
antiprotozoal drug target because the 
mechanism and structure of the protozoan RNA 
triphosphatases are completely different from 
those of the RNA triphosphatases found in 
mammalian and arthropod hosts. Here, we 
report several crystal structures of the 
catalytically active form of TcCet1 complexed 
with a divalent cation and an inorganic 
tripolyphosphate in the active-site tunnel at 
2.20–2.51 Å resolutions. The structures revealed 
that the overall structure, architecture of the 
tunnel, and arrangement of the metal-binding 
site in TcCet1 are similar to those in other TTM 
proteins. On the basis of the position of three 
sulfate ions that co-crystallized on the positively 
charged surface of the protein, and results 
obtained from mutational analysis, we identified 
an RNA-binding site in TcCet1. We conclude 
that the 5' end of the triphosphate RNA 
substrate enters the active-site tunnel 
directionally. The structural information 
reported here provides valuable insight into 
designing inhibitors that could specifically block 
the entry of the triphosphate RNA substrate into 
the TTM-type RNA triphosphatases of T. cruzi 
and related pathogens. 
________________________________________ 
Trypanosomatid parasites belong to the order 
kinetoplastida that causes several neglected 
diseases of humans and animals affecting close to 
100 million people worldwide, including African 
sleeping sickness caused by Trypanosoma brucei, 
Chagas disease caused by Trypanosoma cruzi, and 
a spectrum of diseases caused by various 
Leishmania species (1). New therapeutics against 
trypanosomatids are needed as current medications 
are generally ineffective at late-stage of infection or 
have severe side effects (2). 
The 5’-cap (m7Gp) is an essential feature 
in eukaryotic cellular and viral mRNAs that 
functions to protect mRNA from degradation and to 
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promote translation initiation. RNA triphosphatase, 
which catalyzes the first step in mRNA capping, is 
a promising target for anti-protozoal drug 
development because the mechanism of protozoan 
RNA triphosphatase is completely different from 
mammalian or arthropod host (3, 4). Metazoan and 
plant RNA triphosphatases belong to the cysteine-
phosphatase enzyme superfamily that catalyzes a 
two-step phosphoryl transfer reaction in which the 
active site cysteine in the phosphate-binding loop 
attacks the γ-phosphate of triphosphate-terminated 
RNA (pppRNA) to form a covalent protein-
cysteinyl-S-phosphate intermediate and release the 
diphosphate RNA product in the absence of metal 
cofactor (5, 6). The RNA triphosphatases of fungi, 
protozoa, and several DNA viruses belong to a 
triphosphate tunnel metalloenzyme (TTM) family 
that hydrolyzes γ-phosphorus of pppRNA in the 
presence of magnesium, and NTP in the presence 
of either manganese or cobalt (7-17). The crystal 
structure of Saccharomyces cerevisiae RNA 
triphosphatase (Cet1) revealed that the catalytic 
core is located in a topologically closed hydrophilic 
tunnel composed of 8 antiparallel β-strands (18). 
The Cet1 active site constitutes of 15 essential 
amino acid side chains that either stabilize the 
topology of the tunnel, or make contacts to the 
divalent cation or sulfate ion (7, 19-21). The 
position of the sulfate ion was proposed to reflect 
the position of γ-phosphate of pppRNA and NTP, 
or the leaving group phosphate (18). Two 
glutamate-containing motifs (designated as motif A 
and C) comprise the metal binding site and are 
conserved among all TTM family members (22-24). 
RNA triphosphatases from kinetoplastids 
have been characterized in T. brucei (TbCet1) and 
T. cruzi (TcCet1) (10, 11). Based on the primary 
structures of TbCet1 and TcCet1, the kinetoplastid 
enzymes contain all the putative counterparts of β-
strands that comprise the yeast Cet1 triphosphate 
tunnel but lack extra domains appended to the N-
terminal region that are essential for 
homodimerization and interaction with Ceg1 
guanylyltransferase (25-27). TbCet1 is essential for 
procyclic cell growth (28), and can also 
complement the function of yeast Cet1 in S. 
cerevisiae as a cap forming enzyme (11). Several 
classes of small molecular weight compounds have 
been reported to inhibit the triphosphatase activity 
of TbCet1 and mutagenesis studies have 
illuminated functional groups that are important for 
catalytic activity (28-30). What remains obscure is 
the structural basis of inhibition and the selectivity 
for the RNA substrate. 
In the present study, we produced a 
catalytically active form of TcCet1 and crystallized 
the enzyme in complex with divalent cation and 
tripolyphosphate (PPPi) bound at the active site. 
We propose that 5'-end of triphosphate terminus of 
RNA substrate directionally enters the active site 
tunnel through a positively charged surface based 
on the three sulfate ions that co-crystallized with 
TcCet1. The structural information could provide 
valuable insight into designing inhibitors that could 
specifically block the entry of triphosphate RNA 
substrate in TTM-type RNA triphosphatases. 
 
Results 
 
Defining the minimal catalytic unit of 
Trypanosoma RNA triphosphatase - Deletion and 
limited proteolysis analyses of TbCet1 suggest that 
the hydrophilic N-terminal ~20 amino acid segment 
is connected by protease-sensitive site and is 
dispensable for triphosphatase activity (30). To 
define the minimal catalytic core for structural 
analysis, we deleted several amino acids from N- 
and C-termini in TcCet1 [TcCet1(18-243)], and 
further made an internal deletion to remove a 
putative protease-sensitive loop [TcCet1(18-243 
Δ55-75); Figure 1 and Supporting Information 1].  
Similar deletions were made for TbCet1 
[TbCet1(29-253) and TbCet1(29-253 Δ62-90)]. 
The truncated TcCet1 and TbCet1 proteins were 
expressed in bacteria and purified from a soluble 
extract by Ni-agarose chromatography, and 
proteins were assayed for a release of 32Pi from [γ-
32P]ATP in the presence of 2 mM manganese. 
Removal of N-terminal region apparently increased 
the ATPase activity of TcCet1 and TbCet1, 1.3 and 
2.6-fold, respectively, in comparison to their full-
length enzymes (Supporting Information 1B). 
TcCet1(18-243 Δ55-75) and TbCet1(29- 253 Δ62-
90) showed a modest reduction in the activity; 90% 
and 60% of full-length enzymes, respectively. 
TcCet1(18-243 Δ55-75) had similar activity to the 
full-length TcCet1 in hydrolyzing pppRNA 
(Supporting Information 1C). We conclude that 
removal of putative protease-sensitive loop region 
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3 
does not significantly affect the triphosphatase 
activity.   
 
Crystallization and Structure Determination of 
TcCet1(18-243 Δ55-75) – PPPi is a potent 
competitive inhibitor of TbCet1, suggesting that 
PPPi binds tightly to the active site of the enzyme 
(31). While TbCet1 is capable of hydrolyzing PPPi, 
tripolyphosphatase activity is only 0.5% of its 
NTPase activity. We therefore co-crystallized 
TcCet1(18-243 Δ55-75) in the presence of PPPi 
and manganese. (Experimental Procedures). The 
crystal was further soaked with potassium iodine to 
improve the mosaicity to obtain experimental phase 
information. The structure was then refined at 2.20 
Å resolution with R/Rfree of 22.6% / 26.1% 
(Supporting Information 3). The electron density 
corresponding to PPPi was evident and a density for 
manganese was modeled adjacent to PPPi. We 
subsequently solved the structure of TcCet1(18-243 
Δ55-75) in complex with Mn alone, by means of 
molecular replacement phasing method using the 
TcCet1(18-243 Δ55-75) Mn•PPPi structure as a 
search model. The root mean square deviations 
between pairs of structures was 0.9 Å for the main 
chain atoms of residues 37–242, suggests that 
binding of PPPi may not induce conformational 
change. Efforts to crystallize full-length TcCet1 
and TbCet1 and other derivatives of the proteins 
were unsuccessful.  
Two unique interfaces are formed in the 
structure of TcCet1(18-243 Δ55-75) (Supporting 
Information 3). The dimer-forming interface in the 
Mn-bound and Mn•PPPi-bound forms differ in the 
position of N-terminal α-helix (from residues 
Asp18 to Leu36). Analysis with the PDBePISA 
server (32) reveals the Mn-bound dimer interface 
buries 663.9 Å2 with a Complex Formation 
Significance Score (CSS) of 0.000, suggests that 
this interaction occurs only in the crystal. In the 
Mn•PPPi-bound form, the N-terminal α-helix is 
extended and protrudes from one protomer to the 
other, with an interface area of 654.1 Å2 and the 
calculated CSS of 0.440, suggests that the interface 
plays an auxiliary role in complex formation. 
However, identical contact is formed by the 
monomeric enzyme, where the N-terminal α-helix 
folds back by a connecting loop (Supporting 
Information 3C). Indeed, TcCet1 behaves as a 
monomer in solution at micromolar concentration, 
as judged by gel filtration analysis, and as 
previously noted (10). Thus, the two independent 
molecules of TcCet1 found in the asymmetric unit 
in Mn•PPPi-bound form can be described as a 
dimer formed by a crystal packing. 
 
Structure of TcCet1 with tripolyphosphate in the 
active site - The overall structure of TcCet1(18-243 
Δ55-75) is similar to other TTM proteins, 
composed of eight-stranded anti-parallel β-barrel 
with three α-helices surrounding the active site 
tunnel (Figure 2A). Structural comparison to yeast 
RNA triphosphatase Cet1 reveals that diameter of 
the tunnel and the metal binding site is nearly 
identical between the two enzymes (Figure 2C - 
2E). Positions of 15 side-chains in Cet1 active site 
tunnel are conserved in TcCet1 (Figure 2B and 2E), 
of which 14 side-chains were shown to be essential 
for Cet1 (7, 19, 21) and TbCet1 (30) triphosphatase 
activity. Three glutamates (Glu42, Glu44, and 
Glu210) from motif A and C from the tunnel floor 
coordinate the Mn2+, and allows Mn2+ to interact 
with the PPPi at P1 and P2 positions (Figure 2F). 
The basic side chains (Arg118 and Lys138) 
extended from the other side of the tunnel likely 
stabilize the interaction with PPPi. Lys182 and 
Arg184 interact with central phosphate (P2 
position), and Lys138 interacts with phosphate at 
P3 position of PPPi (Figure 2F). A similar mode of 
PPPi binding and the metal arrangement was 
observed in the structures of Arabidopsis protein 
AtTTM3· Mn•PPPi complex (24, 33). In TcCet1, 
Arg46 also forms water-mediated contact to Glu44 
and Glu210.  
Based on the configuration between Mn2+ 
and PPPi, Mn2+ could facilitate the hydrolysis of 
phosphate at P1 position. Hence, we predict that γ-
phosphate of pppRNA and NTP will be situated at 
the position of P1 phosphate. In support of this 
view, superimposition of TcCet1 and yeast Cet1 
structures reveal that P1 phosphate of PPPi is in 
close proximity to the sulfate ion present in Cet1 
structure (Figure 2E), which has been proposed to 
mimic the position of γ-phosphate of pppRNA and 
NTP (18).  
 
Screen for TcCet1 ligand by fluorescent-based 
protein thermal stability shift assay - We 
performed a fluorescent-based protein thermal 
stability shift assay to identify potential ligand that 
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4 
can interact to stabilize the TcCet1 protein. In this 
procedure, TcCet1(18-243 Δ55-75) was incubated 
with CYPRO Orange dye, which preferentially 
binds to the hydrophobic core of the protein and 
emits fluorescence when the protein is unfolded by 
temperature shift. We determined that Tm of 
TcCet1(18-243 Δ55-75) was 44.6°C, and the 
addition of 2 mM ATP increased the Tm by 1.4°C 
to 46.0°C (Figure 3A).  
We screened for compounds that can bind 
and increase the Tm of TcCet1(18-243 Δ55-75) 
using an in-house chemical compound library 
consists of 965 commercially available low 
molecular weight compounds (Figure 3A). We 
identified four compounds that increase the Tm of 
TcCet1(18-243 Δ55-75) more than 1.0°C when 
present at 2 mM concentration [#466 (C13H13NO2; 
Tm = 46.23°C), #695 (C10H11N2O2; Tm = 45.58°C), 
#860 (C11H12N2O; Tm = 46.23°C) and 
#951(C10H14N4O2; Tm = 45.58°C)]. The chemical 
structures of these compounds are shown in Figure 
3B. In addition, we identified ten compounds that 
lower the Tm of TcCet1(18-243 Δ55-75) to below 
37°C. The structures of these compounds are shown 
in Supporting Information 4. 
 
Structure of TcCet1 in complex with ligands	- We 
attempted to co-crystallize TcCet1(18-243, Δ55-
75) with the four compounds identified from the 
above screen that stabilize the enzyme. Only the 
complex formed with compound #951 
(C10H14N4O2) crystallized with satisfactory quality 
for X-ray crystal diffraction analysis. By soaking 2 
mM of compound #466 (C13H13NO2) in to 
C10H14N4O2 bound crystal, we also obtained the 
structure of TcCet1(18-243, Δ55-75)· C13H13NO2. 
The structures of TcCet1(18-243, Δ55-75) with the 
ligands were solved at 2.39Å (complex with 
C10H14N4O2) or 2.51Å (complexed with 
C13H13NO2) resolution using TcCet1(18-243 Δ55-
75) Mn•PPPi bound structure as a search model 
(Figure 4A and 4B).  The bound ligands were well 
defined in the electron-density maps (Supporting 
Information 5), and bound on the same surface of 
the protein that forms a helical loop between amino 
acid residues 166 -177, a region that was disordered 
in both Mn and Mn•PPPi-bound structures. Neither 
Mn nor PPPi is evident in both ligand-bound 
structures and the tunnel cavities are slightly 
narrower compared to the Mn- or Mn•PPPi-bound 
structures (Figure 4).  
Two aromatic residues, Phe169 from the 
loop and Trp117 from β4-strand, interact with 
C13H13NO2 and C10H14N4O2 through π-π stacking. 
The C13H13NO2 oxo-groups are hydrogen bonded 
by His119 and Asp165 side chains (Figure 4C). 
Similarly, one of the oxo-groups in C10H14N4O2 
forms a hydrogen bond with His119 side chain, and 
other oxo-group is stabilized by Arg115 (Figure 
4D). Neither compound had a substantial effect on 
the triphosphatase activity of TcCet1, up to 1 mM 
concentration (Figure 4E). Point mutations in 
Phe169 and His119, did not have significant impact 
on the triphosphatase activity, although Trp117 
mutation showed moderate effect with 20 - 50% of 
WT activity (Figure 4F and 4G). These results 
indicate that ligand binding site is not essential for 
TcCet1 activity and ligand bound structures 
constitute an active form of the enzyme. 
 
Sulfate ions bound on the surface of TcCet1 reveal 
the entry site for triphosphate RNA - The striking 
feature of C13H13NO2 and C10H14N4O2 bound 
structures is that three sulfate ions, designated as 
SO4-a, SO4-b, and SO4-c, were bound on the same 
positively charged surface of the protein (Figures 
5A and 5B). The distance between the three 
consecutive sulfur atoms is ~ 6 Å each (S-S 
distance), which is similar to the distance between 
the two phosphorus atoms on a single-stranded 
RNA (Figure 5C). We predict that three 
consecutive sulfate ions reflect the position of 
backbone phosphate on the RNA chain. 
Superposition of the ligand-bound and the PPPi-
bound structures reveals that SO4-a is situated 12.6 
Å (S-P distance) from the nearest phosphate on the 
PPPi in the active site tunnel, suggesting that SO4-
a likely occupies the position of phosphate between 
2nd and 3rd nucleotide of the RNA substrate. SO4-
b and SO4-c may occupy the positions between 3rd 
and 4th, and 4th and 5th nucleotides on the RNA, 
respectively. 
We hypothesize if the three sulfate ions 
found in the structure of TcCet1 reflect the position 
of phosphodiester bonds of the RNA substrate, 
mutation in the residues surrounding the bound 
sulfate ions may affect the RNA triphosphatase 
activity, but retains its ability to hydrolyze NTP. 
Alanine substitution was introduced at two 
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5 
positively charged residues, Arg156 and Lys144, 
that coordinates SO4-a and SO4-c, respectively 
(Figure 5C). Phe50 and Phe79 were also selected, 
because these aromatic residues may participate in 
stacking interaction with the RNA bases. In 
addition, Arg-58, situated within the internal 
deletion of TcCet1(18-243 Δ55-75), was 
substituted to alanine as a positive control.  
The full-length wild-type and Ala-
substituted TcCet1 proteins were produced in 
bacteria (Figure 6A). The RNA triphosphatase and 
ATPase activities were assayed for the release of 
32Pi from 1 µM [γ-32P]pppRNA and [γ-32P]ATP, 
respectively (Figure 6B and 6C). The specific 
activities were calculated from the average of the 
slopes of the titration curves in the linear range of 
enzyme-dependence. Under this condition, TcCet1 
can preferentially hydrolyze pppRNA, 5.4-fold 
higher than that for ATP (Figure 6D). The R156A 
mutation showed significantly reduced RNA 
triphosphatase activity compared to the WT 
enzyme. The ratio of pppRNA hydrolysis / ATP 
hydrolysis was 0.4, suggests that R156A is 
selectively impaired for hydrolyzing triphosphate 
RNA (13.5-fold lower compared to the WT 
enzyme). F50A and F79A display reduced 
pppRNA and ATP hydrolysis compared to the WT 
enzyme.  The ratio of pppRNA / ATP hydrolysis by 
F50A and F79A was 2.4 and 0.6, respectively, 
implies that F79A was less active in hydrolyzing 
pppRNA than the ATP. K117A and R58A 
displayed near WT activity in hydrolyzing 
pppRNA and ATP. Consistent with our findings, 
F50A, F79A and R156A mutations show 
significant reduction in binding to the nucleic acid, 
while R58A and K144A mutants maintained wild-
type binding (Supporting Information 6). Taken 
together, these results support the notion that three 
sulfate ions found in the structure of TcCet1 reflect 
the position of phosphodiester bonds on the RNA, 
and the 5’- end of the RNA likely enters the active 
site tunnel directionally through the positively 
charged nucleic-acid binding surface. 
 
Discussion 
 
The present study provides new insights into the 
structure and mechanism of TTM-RNA 
triphosphatase by capturing structures of 
catalytically active TcCet1 in complex with 
manganese and PPPi. The catalytic domain of 
TcCet1 adopts a characteristic TTM-enzyme fold 
with eight-stranded antiparallel β-barrel, and the 
arrangement of the metal-binding site is similar to 
other TTM-enzymes (18, 23).  The RNA must bind 
near one of the tunnel openings to allow the 5’-
triphosphate terminus to enter the active site. We 
further co-crystallized TcCet1 with the two 
phenolic compounds that were identified to 
stabilize the TcCet1. The crystals were grown in the 
presence of ammonium sulfate, and the TcCet1-
ligand complexes contained three sulfate ions on an 
electrostatically positive surface near the tunnel 
entrance. Each sulfate ions are separated by ~ 6 Å, 
similar to the distance between consecutive 
phosphates in single-stranded RNA. The distance 
between the PPPi found in the active site tunnel and 
to the closest surfer atom was 12 Å. We predict that 
sulfate ions reflect positions of 2nd 
(pppN1pN2pN3pN4p), 3rd (pppN1pN2pN3pN4p) and 
4th (pppN1pN2pN3pN4p) backbone phosphate on 
the pppRNA substrate. 
Two metal binding sites were identified in 
the structures of other TTM members, including 
AtTTM3 polyphosphatase (24), ygiF 
polyphosphatase (24), and adenylate cyclase CyaB 
(34). The second metal ion participates in binding 
of the substrate, coordinating the triphosphate, or 
stabilizing the diphosphate leaving group for 
optimal catalysis. TcCet1 may employs two metal 
catalytic mechanism, as previous studies suggest 
that TbCet1 and other RNA triphosphatase exhibit 
synergistic activation by magnesium and 
manganese (30, 35). However, only a single metal 
was found in the structure of TcCet1(18-243 Δ55-
75). We speculate that second metal is absent in the 
structure because PPPi lacks the nucleoside moiety 
found in NTP and pppRNA. Alternatively, an extra 
negative charge on the PPPi, which is not present in 
NTP or pppRNA, may cause interference with the 
binding of the second metal.  
Mutational analysis of selected amino acids 
on the sulfate binding surface identified Arg156 to 
be important for the RNA triphosphatase activity. 
Alanine substitution of Arg156 severely reduced 
RNA triphosphatase activity, but the mutant protein 
resulted in a 2-fold increase in NTPase activity. The 
Arg156 reside is located at the entrance of the 
tunnel, and is conserved as arginine or lysine in 
cellular TTM-type RNA triphosphatases 
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6 
characterized to date, but is not present in other 
TTM-enzymes (13, 15, 23). TcCet1 Arg156 
counterpart for Cet1 is Lys427. Substitution of Cet1 
Lys427 with Glu exhibits a cold sensitive growth 
arrest phenotype in yeast, suggests that positive 
charge residue at this position could be important 
for the Cet1 function in vivo (36). Two aromatic 
residues, Phe50 and Phe79, in the vicinity of sulfate 
ions were also crucial for TcCet1 RNA 
triphosphatase activity, suggesting that these 
aromatic residues may participate in stacking 
interaction with the nucleoside bases on the RNA. 
The effect of F79A substitution appeared to be 
much more severe than F50A, as Phe79 is 
positioned closer to the tunnel entrance than Phe50 
and may have greater impact on stabilizing the 5’-
end of the RNA.   
The TTM-enzyme fold and the active site 
architecture are evolutionarily conserved but have 
different substrate specificity to hydrolyze 
phosphate. We propose that 5’-end of nascent RNA 
enters the triphosphate tunnel directionally, through 
the positively charged RNA binding surface to 
allow the γ-phosphate to be aligned in the active site 
tunnel. This view is supported by cryo-EM and CX-
MS analysis of yeast capping enzyme in complex 
with RNA polymerase II (37). In their model, the 
5’-end of the newly synthesized RNA enters the 
Cet1 tunnel cavity in the same direction as we 
proposed for TcCet1. The directionality of substrate 
binding has been proposed to dictate the cleavage 
specificity of TTM (22, 24). Thiamine 
triphosphatase hydrolyzes thiamine triphosphate 
(TTP) into thiamine diphosphate and Pi, but is 
unable to hydrolyze pppRNA. The α-helix at the C-
terminal end protrudes into the tunnel to interacts 
with thiamine to orient the terminal phosphate for 
hydrolysis reaction, in the same direction as we 
proposed for TcCet1 (24). Similar C-terminal plug-
in helix is also present in AtTTM3 
tripolyphosphatase (24, 33), but is absent in TcCet1. 
The C-terminal plug-in helix may also function to 
block the unwanted substrate from entering the 
tunnel cavity, which may explain why thiamine 
triphosphatase and AtTTM3 cannot hydrolyze 
pppRNA. In the crystal structure of class IV 
adenylate cyclase, ATP is bound in a reverse 
orientation in the active site tunnel, compared to the 
TTP of the Thiamine triphosphatase (24, 34). This 
conformation of ATP allows the α-phosphate to 
position in a suitable orientation for an in-line 
nucleophilic attack by ribose O3’ at the cleavage 
site. Because TcCet1 can also hydrolyze γ-
phosphate from NTP, we predict that triphosphate 
on the NTP will enter the tunnel in the same 
direction as pppRNA. In contrast, symmetric 
molecule such as PPPi may enter from either side 
of the tunnel. This may partly explain why PPPi is 
a potent inhibitor for the triphosphatase activity 
(31). 
In summary, we solved the structures of 
TcCet1 and illuminate the mechanism on how RNA 
substrate is being recognized and how the 
triphosphate end enters the active site tunnel. The 
structural information of TcCet1 could be exploited 
in the development of effective inhibitor that could 
specifically block the entry of RNA substrate in 
TTM-type RNA triphosphatase.  
 
Experimental Procedures 
 
Expression plasmids for TcCet1 and TbCet1 - The 
bacterial expression plasmid pET44-TcCet1 
encodes T. cruzi RNA triphosphatase fused in 
frame to an N-terminal His-tag with a custom 
HRV3C protease recognition site. This was 
accomplished by amplifying the TcCet1 open 
reading frame from T. cruzi (Tulahuen strain) 
genome by PCR and inserting into modified pET44, 
in which the plasmid segment encoding for 
Nus·Tag, S·Tag and thrombin cleavage segments 
were replaced with His-tag and HRV3C protease 
recognition site between Nde1-BamH1 sites. 
Truncated allele TcCet1(18-243) was generated by 
PCR amplification using mutagenic sense primer 
that replaces Gly17 with methionine and antisense-
strand primer that introduced stop codon in lieu of 
the codons for Ser244, and the fragment was 
inserted between Nde1-Sal1 restriction site from 
pET-TcCet1 template. TcCet1(18-243 Δ55-75) 
allele spanning from residue 18 to 243 with an 
internal deletion from 55 to 75 amino acids, and 
point mutations in TcCet1 gene, were generated by 
synthetic oligonucleotides using the two-stage 
PCR-based overlap extension strategy. T. brucei 
RNA triphosphatase was amplified by PCR from 
pET-His/Smt3-TbCet1 (11) and inserted into 
pET44a plasmid between NdeI and SalI restriction 
site. Plasmids for expression of TbCet1(29-253) 
and TbCet1(29-253 Δ62-90) were generated by 
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similar strategies described for TcCet1(18-243) and 
TcCet1(18-243 Δ55-75). The presence of the 
desired mutation was confirmed in every case by 
sequencing the entire insert. For deletion and 
mutational analysis, plasmids were transformed 
into E. coli BL21 (DE3) and proteins were purified 
from the soluble lysates by Ni-NTA column as 
described (11). 
 
Large scale purification of TcCet1(18-243 Δ55-
75) - E. coli BL21 (DE3) transformed with pET-
TcCet1(18-243 Δ55-75) was grown in LB medium 
(6 liters) with 0.1 mg/mL ampicillin at 37°C until 
the absorbance at 600 nm reached 0.6. The 
expression of TcCet1(18-243 Δ55-75) was induced 
by addition of isopropyl β-d-1-
thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM. The temperature was 
reduced to 16°C following induction and the cells 
were incubated for another 12–16 hours. Bacteria 
were harvested by centrifugation and resuspended 
in lysis buffer [50 mM Tris-HCl (pH 8.0), 0.3 M 
NaCl, 10 mM imidazole, 2 mM MnCl2 and 1 mM 
DTT], sonicated on ice, and centrifuged. The 
supernatant was mixed with Ni-NTA sepharose 
resin that had been equilibrated with lysis buffer, 
and the suspension was mixed by continuous 
rotation at 4°C for 1 h. The Ni-sepharose resin was 
poured into a column. The packed column was 
washed with lysis buffer containing 20 mM 
imidazole, and the N-terminal His-tag was cleaved 
by GST-fused HRV3C protease on the column at 
4°C for 16 hrs. Tag-less TcCet1(18-243 Δ55-75) 
was recovered from Ni-NTA column by elution 
buffer [50 mM Tris-HCl (pH 8.0), 0.1 M NaCl, 20 
mM imidazole, 2 mM MnCl2 and 1 mM DTT]. The 
eluate was passed through Q-sepharose (3 mL, GE 
healthcare) column and then to GS4B (3 mL, GE 
healthcare) column and the flow-through fractions 
were collected for each step. The GS4B flow-
through fraction was concentrated by Amicon-Ultra 
(M.W.C.O = 10 kDa) between 20-30 mg/ml, and 
approximately 15 mg of protein was applied to 
Superdex75 gel filtration column (GE healthcare) 
equilibrated with 10 mM HEPES (pH 7.5), 2 mM 
MnCl2 and 100 mM NaCl. Peak fractions 
containing the recombinant protein were collected, 
concentrated to ~ 15 mg/ml, and stored at -80°C. 
Purified TcCet1(18-243 Δ55-75) was used for 
crystallization and thermal shift assay. 
 
Crystallization, data collection, and structure 
determination - Crystallization was performed by 
hanging drop vapor diffusion method at 20°C. 
Purified TcCet1(18-243 Δ55-75) (7.5 mg/ml) with 
a drop size of 1 µL was mixed with 1 µL of 
reservoir solution. Mn-bound form of crystal was 
obtained in 0.1 M HEPES-NaOH (pH 7.0 - 7.5), 
14–20% PEG 20000. Tripolyphosphate (PPPi) was 
added to a protein sample at 2.5 mM concentration 
prior to mixing with reservoir solution. The 
Mn•PPPi bound form was crystalized in 0.1 M 
sodium acetate (pH 5.0) and 14–18% 1,4-butandiol. 
Compound #951 (C10H14N4O2: 1,3-dimethyl-7-
propyl-purine-2,6-dione) was purchased from 
(ChemBridge Corp.) and was added to a protein 
sample at 2 mM concentration with 2% DMSO, and 
then crystallized in 0.1 M HEPES (pH 7.5), 1.4–1.6 
M ammonium sulfate. Compound #466 
(C13H13NO2: 3,4,6,7-tetrahydroacridine-
1,8(2H,5H)-dione) was purchased from 
(Maybridge, Fisher Scientifics). TcCet1(18-243 
Δ55-75) •C10H14N4O2 crystal was soaked with 2 
mM C13H13NO2  twice in  0.1 M HEPES (pH 7.5), 
1.6 M ammonium sulfate, 2% DMSO and 2 mM 
MnCl2 for 1 hour to obtain the C13H13NO2 bound 
form structure. Prior to data collection, crystals 
were transferred to 35% Xylitol containing 
reservoir solution for cryo-protection.  
Diffraction data was collected at BL15A in 
NSRRC (Hsinchu, Taiwan) or BL-1A in Photon 
Factory (Tsukuba, Japan). Data were integrated by 
XDS (38) and scaled by aimless in CCP4 software 
package (39). For I-SAD data collection, the crystal 
was soaked with 0.25 M potassium iodine for 30 
min at 293K. Phenix AutoSol was used for the 
phase determination (40). In the Mn•PPPi complex, 
seven iodine sites in the asymmetric unit were 
located and used for phase determination and 
improvement, which yielded a traceable electron 
density map. The initial figure of merit was 0.327. 
Initial model building was performed by Phenix 
AutoBuild. Iterative rounds of manual adjustment 
in Coot and refinement using Phenix.refine were 
performed for structure refinement. B-factor of 
phosphate atoms (a, b and g) were 89.21, 88.30, 
and 99.52, respectively. 
Other crystal structures were solved by 
molecular replacement using Phaser in Phenix. 
Iodine and Mn•PPPi -bound form structures were 
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used as a search model for the molecular 
replacement. The structures were refined to the 
indicated statistics using iterated rounds of manual 
adjustments in Coot (41, 42), followed by 
refinement using Phenix (40). Final coordinates and 
structure factors were submitted to the PDB under 
accession code 6L7W (Mn complex), 6L7V 
(Mn•PPPi complex), 6L7Y (C13H13NO2 complex) 
and 6L7X (C10H14N4O2 complex). 
 
Thermal Shift Assay - Library of 965 chemical 
compounds were assembled in-house from 
commercially available low molecular weight 
compounds based on ‘Rule of Three’ (molecular 
weight <300, the number of hydrogen bond donors 
≤3, the number of hydrogen bond acceptors ≤3 and 
ClogP is ≤3), as described (43). Compounds were 
stored desiccated and were resuspended with 
DMSO to 100 mM prior to the assay. Thermal Shift 
Assay was carried out with 1 µg of TcCet1-(18-243 
Δ55-75) and CYPRO Orange fluorescent dye 
(Thermo Fisher Scientific) (1:1000 dilution) in 96 
well plates. Reaction mixture contained 10 mM 
HEPES (pH 7.5), 2 mM MnCl2, and 1 mM DTT, 
and 2 mM of each compound. The temperature of 
the plate was raised from 25°C to 70°C by an 
increment of 0.5°C / 5 sec using StepOne Plus Real-
time PCR system (Thermo Fisher Scientific). A 
resulting melting curve was analyzed by Protein 
Thermal Shift Software v1.1 (Thermo Fisher 
Scientific) to determine ΔTm. 
 
Preparation of triphosphate terminated RNA - 
Substrate for RNA triphosphatase assay was 
prepared by in vitro transcription with T7 RNA 
polymerase from a partially duplexed oligo DNA  
(44). Oligonucleotides corresponding to T7 
promoter sequence  
(5’TAATACGACTCACTATA3’)  and 
complementary sequence with poly(dT) stretch 
(5’TTTTTTTTTTTTTTTTTTTTTATAGTGAGT
CGTATTA3’) were annealed to produce a template 
for T7 RNA polymerase. The reaction mixture 
contained 1 mM of [γ-32P] ATP, 20 µM of duplex 
oligo DNA, 1 unit/µL of RNase inhibitor (Toyobo 
Co., Ltd., Japan) and 2.5 units/µL of T7 RNA 
polymerase (New England Biolabs Inc., USA) in 
provided reaction buffer. The reaction was carried 
out for 3 h at 37°C. DNase I (Nippon Gene Co., Ltd., 
Japan) was then added to digest the template oligo 
DNAs, according to manufacturer’s instruction. 
The product was extracted with 
phenol/chloroform/isoamyl alcohol, precipitated 
with ethanol, and was separated on 20 % denaturing 
polyacrylamide gel. The radioactive product that 
migrates between 7 – 9 nts was excised from the gel 
and eluted by TE. The eluate was passed through a 
spin column to remove gel debris. The RNA was 
precipitated with ethanol and was resuspended in 
water. 
 
Triphosphatase Assay - Reaction mixture 
containing 50 mM Tris-HCl (pH 7.5), 2 mM DTT, 
2 mM of divalent cation (MgCl2 or MnCl2) with 
either [γ-32P]ATP or [γ-32P]pppRNA, and indicated 
amount of protein, were incubated for 15 min at 
30°C. The reaction was quenched by the addition of 
EDTA or formic acid. The reaction products were 
separated by PEI-cellulose thin layer 
chromatography (TLC) with 0.45 M ammonium 
sulfate. The TLC plate was exposed to a 
PhosphorImager plate, scanned by BAS-2000 
(FujiFilm, Japan), and quantitated by Image Gauge 
software. 
 
Data Availability - The atomic coordinates and 
structure factors have been deposited into the 
Protein Data Bank (http://www.rcsb.org) under 
PDB entries 6L7V, 6L7W, 6L7X and 6L7Y. All 
other information and data are available from the 
authors upon request. 
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Figure Legends 
 
Figure 1. Structure-based alignment of T. cruzi RNA triphosphatase. Secondary structure of T. cruzi 
RNA Triphosphatase (TcCet1) is shown above the amino acid sequence. TcCet1 amino acids shaded in 
blue correspond to the segments that are removed in TcCet1(18-243 Δ55-75) protein. TcCet1 sequence 
shaded in green (amino acid residues 166–177) correspond to the segment that interacts with C13H13NO2 
and C10H14N4O2, but was disordered in TcCet1(18-243 Δ55-75) Mn and Mn•PPPi-bound structures. The 
amino acid sequences of TcCet1 is aligned with L. major (LmCet1), T. brucei (TbCet1), S. pombe (SpPct1) 
and S. cerevisiae (ScCet1) RNA triphosphatases. The secondary structure of ScCet1 is indicated below the 
aligned sequences. Identical side-chains found in all polypeptides are highlighted in red. Amino acids with 
similar side chains are highlighted in gray. Position of conserved motifs A and C, located within the 
catalytic domain of the metal-dependent RNA triphosphatases are indicated. The alignment was prepared 
by ESPript. The secondary structure assignment was based on DSSP program  
 
Figure 2: Structure of TcCet1(18-243 Δ55-75) in complex with tripolyphosphate in the active site. (A) 
Crystal structure of TcCet1(18-243 Δ55-75) is depicted as cartoon models. Tripolyphosphate (PPPi) is 
shown as stick, and manganese (Mn) is shown as magenta sphere. (B) Cross section of the triphosphate 
tunnel of TcCet1(18-243 Δ55-75). (C) The structure of TcCet1(18-243 Δ55-75) colored in green was 
superimposed on to yeast Cet1(210-549) colored in yellow [(18), PDB 1D8H)]. The sulfate and Mn in 
Cet1(210-549) are depicted as yellow stick and yellow sphere, respectively. (D) The amino acids of TcCet1 
that correspond to active site residues of Cet1, as judged from the structural comparison. Arg180 side chain 
was not visible in Mn•PPPi-bound structure, and therefore was modeled from the Mn-bound structure. (E) 
Superimposition of triphosphate tunnel of TcCet1(18-243 Δ55-75) and Cet1(210-549). The image was 
prepared with PyMOL. (F) The figure highlights the network of bonding interactions that coordinate PPPi, 
Mn and two water molecules (red sphere) in TcCet1(18-243 Δ55-75). The images were prepared with 
PyMOL and LigPlus. 
 
Figure 3. Screening of small molecule that stabilizes TcCet1. (A) Melting temperature (Tm) of 
TcCet1(18-243 Δ55-75) in the presence of 2 mM compounds were determined by thermal shift assay. Tm 
of TcCet1(18-243 Δ55-75) with DMSO (control) is indicated by the red line (44.6 °C), and with ATP is 
indicated by blue line (46.0°C). Four compounds (#466, #695, #860 and #951) that significantly increase 
the Tm are indicated. (B) Structures of compound #466 (C13H13NO2: 3,4,6,7-tetrahydroacridine-
1,8(2H,5H)-dione], compound #695 (C10H11N2O2 : 2-(1H-benzimidazol-1-yl)propanoic acid), compound 
#860 (C11H12N2O: 3-ethyl-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one), and compound #951 (C10H14N4O2: 
1,3-dimethyl-7-propyl-purine-2,6-dione). 
 
Figure 4. Structures of TcCet1 in complex with C10H14N4O2 and C13H13NO2. (A) Crystal structures of 
TcCet1(18-243 Δ55-75) with C13H13NO2 (colored in violet) and (B) C10H14N4O2 (colored in wheat) was 
superimposed with the TcCet1(18-243 Δ55-75) Mn•PPPi bound complex (colored in green). Two segments, 
amino acids 35-39 and 166 -177, were ordered in both C13H13NO2 and C10H14N4O2 bound structures but 
was disordered in Mn•PPPi-bound structure. Close up view of (C) C13H13NO2 and (D) C10H14N4O2 binding 
site on TcCet1(18-243 Δ55-75). The images were prepared with PyMOL and LigPlus. (E) Effect of 
C13H13NO2 or C10H14N4O2 on triphosphatase activity. Reaction mixtures (10 µL) containing 50 mM Tris-
HCl, pH 7.5, 5 mM DTT, 1 mM MnCl2, 0.2 mM [γ-32P]ATP, 4 ng of TbCet1, and 0, 0.002, 005, 0.01, 0.02, 
0.05, 0.1, 0.2, 0.5 or 1.0 mM of either C13H13NO2 (blue circle) or C10H14N4O2 (orange circle), were 
incubated for 15 min at 30°C. The extents of ATP hydrolysis were plotted as a function of ligand 
concentration. The data shown represent the average of three separate experiments with SE bars. (F) 
Aliquots (5 µg) of native wild-type (WT) TcCet1 and mutant proteins were analyzed by SDS-PAGE. 
Polypeptides were visualized by staining with Coomassie Blue dye. Position of WT and mutant TcCet1 
polypeptide is denoted by an arrow. (G) ATPase activity. Reaction mixtures (10 µL) containing 50 mM 
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on M
ay 10, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
  Structure of T. cruzi RNA Triphosphatase 
 
 
   
 
13 
Tris-HCl (pH 7.5), 5 mM DTT, 1 mM MnCl2, 0.2 mM [γ-32P]ATP, and indicated amount of WT and mutant 
TcCet1 proteins were incubated for 15 min at 30 °C. The extents of ATP hydrolysis were plotted as a 
function of input protein. The data shown represent the average of three separate experiments with SE bars. 
 
Figure 5. Sulfate ions bound on the positive surface of TcCet1 (A) The space-filling surface images of 
TcCet1(18-243 Δ55-75) bound to C13H13NO2 was prepared with the program GRASP. Positive surface 
charge potential is shown in blue, and negative potential in red. C13H13NO2 and sulfate ions are shown as 
stick models. (B) Cartoon model of panel (A). PPPi and Mn were modeled on to TcCet1(18-243 Δ55-75) 
•C13H13NO2 structure from the structure of PPPi •Mn bound complex. (C) Close-up view of SO4 binding 
site. Distance between the three sulfur atoms and the distance between sulfur on SO4-(a) to the nearest 
phosphorous of PPPi are indicated by dotted lines. Amino acid residues 54 to 76 are colored in red to 
indicate the region that was deleted in TcCet1, and the asterisk denotes a probable position of Arg58.  
 
Figure 6. Mutational Analysis of putative RNA binding surface of TcCet1. (A) Aliquots of the nickel-
agarose preparations of the wild-type and mutant TcCet1 proteins (5 µg) indicated were analyzed by SDS-
PAGE, and visualized by staining with Coomassie Blue dye. (B) RNA triphosphatase activity. Reaction 
mixtures contained 1 µM of  [γ-32P]triphosphate-terminated RNA, 2 mM MgCl2 with WT or mutant proteins 
as specified. The data shown represent the average of three separate experiments with SE bars. (C) ATPase 
activity. Reaction mixtures contained 1 µM of [γ-32P]ATP, 2 mM MnCl2 with WT or mutant proteins as 
specified. The extent of Pi release is plotted as a function of input enzyme. The data shown represent the 
average of three separate experiments with SE bars. (D) Efficiency of RNA hydrolysis vs ATP hydrolysis. 
The specific activity of WT and mutant TcCet1 RNA triphosphatase and ATPase activates were calculated 
from the data presented in (B) and (C), and expressed as a ratio of RTPase / ATPase activates and plotted 
for each protein indicated.  
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insights into how it recognizes the 5' end of the RNA substrate
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 published online May 7, 2020J. Biol. Chem. 
  
 10.1074/jbc.RA119.011811Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
 at TSU
K
U
BA
 D
A
IG
A
K
U
 on M
ay 10, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
[A] [C] 2512
[A]18 243[C]
18 [A] [C] 243
TcCet1
2 253[A]
25329 [A]
29 [A] 253
[C]
[C]
[C]
TcCet1(18-243)
TcCet1(18-243 Δ55-75)
TbCet1
TbCet1(29-253)
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Supporting Information 1. Deletion analysis of Trypanosoma RNA triphosphatase. (A) Schematic 
diagram of full-length TcCet1, TcCet1(18-243), TcCet1(18-243 Δ55-75), TbCet1, TbCet1(29-253) 
and TbCet1(29-253 Δ62-90) are shown. Internal deletion is indicated by a dash. Position of 
conserved motifs, A and C, are indicated. (B) ATPase activity. Reaction mixtures (50 µL) 
containing 50 mM Tris-HCl (pH 7.5), 2 mM DTT, 2 mM MnCl2, 0.2 mM [γ-32P]ATP, and 5 ng of 
full-length and truncated proteins were incubated at 30°C. Aliquots were withdrawn at the indicated 
time and Pi release was plotted as a function of time. (C) RNA triphosphatase activity of TcCet1 
and TcCet1(18-243 Δ55-75). Reaction mixtures (10 µL) containing 50 mM Tris-HCl, pH 7.5, 2 mM 
DTT, 2 mM MgCl2, 1 µM [γ-32P]pppRNA, and indicated amount of full-length TcCet1 and 
TcCet1(18-243 Δ55-75) were incubated at 30°C for 15 min. Pi release was plotted as a function of 
input protein. The data shown represent the average of three separate experiments with SE bars. 
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Supporting Information 2
Data collections and refinement statistics of the Trypanosoma cruzi  RNA Triphosphatase, TcCet1(18-243 Δ55-75) , crystals
Ligand(s) Mn2+, PPPi and I- Mn2+ Compound #951 Compound #466
PDB ID 6L7V 6L7W 6L7X 6L7Y
Data Collection
Beamline Photon Factory, BL1A NSRRC, BL15A Photon Factory, BL1A Photon Factory, BL1A
Wavelength (Å) 1.9000 1.0000 1.1000 1.1000
Resolution range 33.63  - 2.20 (2.28  - 2.2) 47.9  - 2.60 (2.72  - 2.60) 49.65  - 2.39 (2.48  - 2.39) 49.40  - 2.51 (2.61  - 2.51)
Space group P3 2 21 P 21 P3 2 21 P3 2 21
Unit cell a,b,c 67.3, 67.3, 76.8 52.4, 73.2, 63.7 114.7, 114.7, 56.7 115.9,115.9, 56.7
β = 114.1
Total reflections 409654 51598 176432 147972
Unique reflections 10613 13646 17288 15320
Multiplicity 38.6 3.8 10.2 9.7
Completeness (%) 100.0 (99.7) 99.6 (98.7) 100.0 (100.0) 99.7 (98.2)
Mean I/sigma(σ) 33.5 (0.7) 9.9 (1.7) 14.9 (1.7) 16.6 (1.8)
Wilson B-factor 39.4 40.1 45.1 57.2
R-merge 0.095 (5.854) 0.121 (0.860) 0.101 (1.843) 0.083 (1.208)
R-meas 0.096 (5.939) 0.142 (1.054) 0.106 (1.934) 0.087 (1.273)
CC1/2 1.000 (0.955) 0.996 (0.709) 0.999 (0.771) 0.999 (0.927)
Phasing
Number of sites 7 - - -
Figure of merit 0.327 - - -
Refinement
R-work 22.6 23.9 20.4 20.1
R-free 26.1 29.4 23.8 24.0
Number of non-hydrogen atoms 1449 2893 1675 1657
    macromolecules 1402 2850 1612 1613
    ligands 21 2 36 36
    solvent 26 41 27 8
Protein residues 180 362 203 203
RMS(bonds) 0.004 0.005 0.004 0.004
RMS(angles) 0.97 0.98 0.95 0.99
Ramachandran favored (%) 95.9 97.7 98.0 97.5
Ramachandran allowed (%) 4.1 2.3 2.0 2.5
Ramachandran outliers (%) 0.0 0.0 0.0 0.0
Rotamer outliers (%) 3.4 1.3 1.2 0.6
Average B-factor 61.2 56.0 67.0 67.6
    macromolecules 60.3 56.2 66.8 66.8
    ligands 133.5 53.5 98.8 101.7
        Mn annd PPPi 97.6 - - -
       iodine 205.2 - - -
    solvent 49.4 43.6 56.5 74.8
*Highest resolution shells are shown in parenthesis
BA
N-terminal helix
N-terminal helix
Protomer A
Protomer B
Protomer B
Protomer A
C
Supporting Information 3. Crystal structures of TcCet1(18-243 Δ55-75). (A) Mn-bound 
structure. Ordered amino acids in protomer A/B include 18–50, 79-165, 178-218, 220-242/ 20-51, 
79-114, 116-164, 180-215, 219-242. (B) Mn•PPPi-bound structure. The ordered amino acids 
include 18–51, 77-112, 117-164, 179–217, 220–242. (C) Superimposition of Mn-bound and 
Mn•PPPi-bound structure of TcCet1(18-243 Δ55-75). Note that position of N-terminal helix 
(amino acid residues 19-36) in the protomer A of the Mn-bound form (green) and protomer B of 
the Mn•PPPi bound form (orange) overlap each other.
Compound # 818
Tm = 36.2°C
ΔTm =  - 8.4°C
Compound # 521
Tm = 35.8°C
ΔTm =  - 8.8°C
Compound # 524
Tm = 35.8°C
ΔTm =  - 8.8°C
Compound # 809
Tm = 33.0°C
ΔTm =  - 11.5°C
Compound # 202
Tm = 37.0°C
ΔTm =  - 7.6°C
Compound # 224
Tm = 34.5°C
ΔTm =  - 10.0°C
Compound # 212
Tm = 33.6°C
ΔTm =  - 10.9°C
Compound # 378
Tm = 36.9°C
ΔTm =  - 7.7°C
Compound # 375
Tm = 36.0°C
ΔTm =  - 8.6°C
Compound # 332
Tm = 35.7°C
ΔTm =  - 8.8°C
Supporting Information 4. Small molecules that destabilize TcCet1. Melting temperature (Tm) of 
TcCet1(18-243 Δ55-75) in the presence of 2 mM compounds were determined by thermal shift assay 
(Figure 3A). Structures of ten compounds that reduce the Tm to below 37°C are shown.  
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Supporting Information 5. Electron-density of ligands bound to TcCet1(18-243 Δ55-75). Omit 
(Fo-Fc) map of (A) C10H14N4O2; compound #951 and (B) C13H13NO2; compound #466. Omit 
maps are shown as green mesh, contoured at 3 σ. Maps are carved at 2.0 Å around the ligands. 
Proteins are shown in cartoon representations and ligands as sticks colored according to the atom 
type (nitrogen in blue, oxygen in red and carbon in yellow). 
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Supporting Information 6.  Filter binding Assay. Nucleic acid binding of wild type and mutant 
TcCet1 proteins were analyzed by filter binding assay. One pmol of 5’ [32P]-labeled 17-mer 
oligonucleotide was incubated with 10 pmol of protein in a 20 µL buffer containing 50 mM Tris-
HCl (pH 7.5), 2 mM DTT and 50 mM NaCl for 15 min at 23°C. The mixture was then spotted 
onto MF-Millipore membrane filter (Merck), and washed twice with the buffer. The dried 
membrane was exposed to a PhosphorImager plate, scanned by BAS-2000, and quantitated by 
Image Gauge software. The amount of labeled oligonucleotide bound by the WT was defined as 
an arbitrary unit of 1.0, against which all other values were normalized. The average of three 
independent experiments and standard error of the mean are plotted.  
